A Narrative Review of Medicare Part D Medication Therapy Management Program Design Challenges and the Development of an Evidence-Informed MTM Benefit Program for a Large Self-Insured Employer.
- 1Department of Pharmacy Practice, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA.
- 2Central Arkansas Veterans Healthcare System, Little Rock, AR 72205, USA.
- 3Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Abstract
The Medicare Part D Medication Therapy Management (MTM) program has several well-documented challenges, including restrictive eligibility criteria, low patient engagement, and difficulties integrating MTM services into pharmacy workflows and broader healthcare teams. These challenges are often driven by inadequate health information technology infrastructure, limited coordination between pharmacists and prescribers, and inefficiencies in standardized documentation for Comprehensive Medication Reviews (CMRs). This narrative review synthesized published literature to identify challenges and limitations of the Medicare Part D MTM program and used Purdue University's MTM program design documentation to compare program features and describe the evidence and rationale underlying key design decisions. Purdue's MTM program incorporated broader patient eligibility, more frequent MTM services, and provider-developed communication templates to address limitations in patient access, program uptake, and workflow feasibility identified in the Medicare Part D program. However, challenges related to optimization of standardized CMR documentation and integration with electronic health records (EHRs) remained unresolved. Overall, this review demonstrates how evidence-informed program design may strengthen MTM implementation while identifying opportunities for future refinement. Future evaluation of the Purdue MTM program will assess its acceptability, feasibility, adoption, reach, and fidelity.
Related
- Challenges and dilemmas of exercise therapy in the management of osteoporosis: a narrative review
- A precision health approach to medication management in neurodevelopmental conditions: a model development and validation study using four international cohorts
- Antihypertensive Medication Class and Incident Alzheimers Disease and Related Dementias: External Replication Across Two Independent Healthcare Data Sources-the Vanderbilt EHR Synthetic Derivative and US Medicare Claims
- The role, challenges, and innovations of rifampin in the management of periprosthetic joint infections: a narrative review.
- Annual Wellness Visits and New Dementia Medication Prescriptions Among US Medicare Beneficiaries
BibTeX
@article{damen2026narrative,
title = {{A Narrative Review of Medicare Part D Medication Therapy Management Program Design Challenges and the Development of an Evidence-Informed MTM Benefit Program for a Large Self-Insured Employer.}},
author = {Lama Al Damen and Alan J Zillich and Karen Suchanek Hudmon and Geoffrey M Curran and Margie E Snyder},
journal = {Pharmacy (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/pharmacy14070149},
url = {https://europepmc.org/article/MED/42931126},
note = {CC BY},
}
RIS
TY - JOUR
TI - A Narrative Review of Medicare Part D Medication Therapy Management Program Design Challenges and the Development of an Evidence-Informed MTM Benefit Program for a Large Self-Insured Employer.
AU - Lama Al Damen
AU - Alan J Zillich
AU - Karen Suchanek Hudmon
AU - Geoffrey M Curran
AU - Margie E Snyder
PY - 2026
DA - 2026/10/11
JO - Pharmacy (Basel, Switzerland)
DO - 10.3390/pharmacy14070149
UR - https://europepmc.org/article/MED/42931126
AB - The Medicare Part D Medication Therapy Management (MTM) program has several well-documented challenges, including restrictive eligibility criteria, low patient engagement, and difficulties integrating MTM services into pharmacy workflows and broader healthcare teams. These challenges are often driven by inadequate health information technology infrastructure, limited coordination between pharmacists and prescribers, and inefficiencies in standardized documentation for Comprehensive Medication Reviews (CMRs). This narrative review synthesized published literature to identify challenges and limitations of the Medicare Part D MTM program and used Purdue University's MTM program design documentation to compare program features and describe the evidence and rationale underlying key design decisions. Purdue's MTM program incorporated broader patient eligibility, more frequent MTM services, and provider-developed communication templates to address limitations in patient access, program uptake, and workflow feasibility identified in the Medicare Part D program. However, challenges related to optimization of standardized CMR documentation and integration with electronic health records (EHRs) remained unresolved. Overall, this review demonstrates how evidence-informed program design may strengthen MTM implementation while identifying opportunities for future refinement. Future evaluation of the Purdue MTM program will assess its acceptability, feasibility, adoption, reach, and fidelity.
SN - 2226-4787
ER -